The Mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
By Changhan Lee, J. Zeng, B. Drew, T. Sallam, A. Martín-Montalvo, J. Wan, Su-Jeong Kim, H. Mehta, A. Hevener, R. de Cabo and 1 more. Cell Metabolism, 2015
637 citations recorded by the source corpus.
Summary Mitochondria are known to be functional organelles, but their role as a signaling unit is increasingly being appreciated. The identification of a short open reading frame (sORF) in the mitochondrial DNA (mtDNA) that encodes a signaling peptide, humanin, suggests the possible existence of additional sORFs in the mtDNA. Here we report a sORF within the mitochondrial 12S rRNA encoding a 16 amino acid peptide named MOTS-c (mitochondrial open-reading-frame of the twelve S rRNA -c) that regulates insulin sensitivity and metabolic homeostasis. Its primary target organ appears to be the skeletal muscle and its cellular actions inhibit the folate cycle and its tethered de novo purine biosynthesis, leading to AMPK activation. MOTS-c treatment in mice prevented age-dependent and high-fat diet-induced insulin resistance, as well as diet-induced obesity. These results suggest that mitochondria may actively regulate metabolic homeostasis at the cellular and organismal level via peptides encoded within their genome.
Subfields: Physiology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/b2d7b09f56b0ae74a9aafa979412b10057070697
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
Citations in the corpus
- Metabolic Control of Longevity. (2016, background): “MOTS-c promotes thebiosynthesisof anendogenousAMPanalog, 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), which stimulatesAMPKandhencecounteracts diabetes, obesity, andaging (Lee et al., 2015).”